recorded webinar "The Treatment of SUD during COVID-19"

The American College of Medical Toxicology (ACMT) and the American Society of Addiction Medicine (ASAM), co-hosted this webinar.

This session focuses on the following cases:

• A colleague has identified some drug testing results from a professional monitoring program case and is requesting feedback. 

• A 31-year-old contacts an outpatient treatment program to receive treatment for opioid use disorder and has some challenges stabilizing via phone/telehealth contact. 

• A detoxification facility was not able to admit a patient due to fever, cough, and presumed COVID19 positive test. He is quarantined at a local hotel supported by county resources -a department of health representative has asked if 'ambulatory detox' for alcohol dependence could be arranged from an outpatient clinic to the hotel site supporting him 

• A 44-year-old patient with a long history of opioid and stimulant use disorder has taken several doses of his 'two-week' take-home quantity of methadone, which he received due to COVID19 -he usually attends 6/7 days a week. He is given naloxone by his partner and transported to the Emergency Department.